ABYLINK
LIVE

Serial Number

79296215

Owner

Debiopharm International SA

Attorney

Duane M. Byers

Filing Date

Feb 26, 2020

Add to watchlist:

No watchlists yet
View on USPTO

ABYLINK Trademark

Serial Number: 79296215 • Registration: 6481109

ABYLINK is a trademark filed by Debiopharm International SA on February 26, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Debiopharm International SA (17 trademarks)

Forum "après-demain"
Lausanne CH1002 , CH

Entity Type: 99

Trademark Details

Filing Date

February 26, 2020

Registration Date

September 14, 2021

Published for Opposition

June 29, 2021

Goods & Services

Pharmaceutical preparations, namely, pharmaceuticals for use in diagnosing and treating cancers, neurological diseases, cardiac diseases, inflammatory diseases, infectious diseases, and metabolic diseases

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 26, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 3, 2022 FICS
FINAL DISPOSITION PROCESSED
Mar 3, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 14, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Sep 14, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 29, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jun 29, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 9, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 21, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 18, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 17, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 17, 2021 TROA
REFUSAL PROCESSED BY IB
Dec 7, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 17, 2020 RFCS
REFUSAL PROCESSED BY MPU
Nov 17, 2020 RFRR
APPLICATION FILING RECEIPT MAILED
Nov 3, 2020 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 29, 2020 RFCR
NON-FINAL ACTION WRITTEN
Oct 28, 2020 CNRT
ASSIGNED TO EXAMINER
Oct 28, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 28, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 22, 2020 REPR